MoneyWorks4Me

Glenmark Pharmaceuticals informs about disclosure of related party transactions

20 May 2023 Evaluate

Pursuant to Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Glenmark Pharmaceuticals has submitted the disclosure of Related Party Transactions for the half year / six months ended 31st March, 2023. The same is also being made available on the website of the Company at www.glenmarkpharma.com.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1783.25
Dr. Reddys Labs. 1202.40
Cipla 1329.50
Lupin 2007.10
Zydus Lifesciences 1154.00
View more..